Abacavir Lamivudin Sandoz, Filmtabletten
7680666870013
CH-66687
Filmtabletten
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Filmtabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
abacavirum
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
abacaviri hydrochloridum monohydricum
|
- | Substance | WIZUS |
|
lamivudinum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
E 110
|
1.415 MG | Substance | HBESI |
|
E 171
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 268.95
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2020
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66687
- Drug name
- Abacavir Lamivudin Sandoz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AR02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 15/12/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ABACAVIR LAMIVUDINE Sandoz 600/300mg 30 pce
- Description (DE)
- ABACAVIR LAMIVUDIN Sandoz 600/300mg 30 Stk
- Market launch
- 15/12/2017
- Market withdrawal
- 07/08/2025
- Narcotic (BTM)
- No
Original drug
Kivexa, Filmtabletten
GTIN: 7680569770021
CHF 311.00